News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
AstraZeneca Pharmaceuticals LP
NEWS
JOBS
IN THE PRESS
NEWS
AstraZeneca PLC: Buy The Dip?
August 4, 2017
·
1 min read
Deals
AstraZeneca PLC Seen as “Tricky” Takeover Target After Big Setback Last Week
August 1, 2017
·
3 min read
FDA
Pharma Giant AstraZeneca PLC Scores Another FDA Breakthrough
August 1, 2017
·
2 min read
Deals
AstraZeneca PLC: Will Pfizer Come Knocking Again?
July 31, 2017
·
1 min read
Drug Development
FDA Calls AstraZeneca PLC and MedImmune’s Imfinzi a Breakthrough
July 31, 2017
·
2 min read
AstraZeneca PLC Shows The Peril Of Going All-In
July 28, 2017
·
1 min read
Drug Development
Why AstraZeneca PLC’s MYSTIC Trial Failure May be a Bad Sign for Bristol-Myers Squibb
July 28, 2017
·
2 min read
Drug Development
AstraZeneca PLC Loses $10 Billion in Value as Long-Awaited MYSTIC Trial Disappoints
July 27, 2017
·
3 min read
Business
AstraZeneca PLC Seals a $8.5 Billion R&D Cancer Tie-Up With Merck & Co.
July 27, 2017
·
3 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Cellectis Announces 2026 Strategy and Catalysts
January 9, 2026
·
7 min read
Press Releases
Rick R. Suarez appointed US President and Head of US BioPharmaceuticals Business Unit
January 8, 2026
·
2 min read
Press Releases
BostonGene and AstraZeneca Announce Strategic Collaboration to Advance Foundation Model-Driven Oncology Development
January 6, 2026
·
2 min read
Press Releases
HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Savolitinib for the treatment of Gastric Cancer Patients with MET Amplification
December 30, 2025
·
5 min read
Press Releases
ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Breakthrough Therapy Designation in the US as post-neoadjuvant therapy for patients with HER2-positive early breast cancer
December 23, 2025
·
19 min read
Press Releases
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer
December 23, 2025
·
20 min read
Press Releases
ENHERTU® Granted Breakthrough Therapy Designation in the U.S. as Post-Neoadjuvant Therapy for Patients with HER2 Positive Early Breast Cancer
December 23, 2025
·
19 min read
Press Releases
Niowave Expands Global Supply Agreement with AstraZeneca to Deliver Actinium-225 for Next-Generation Cancer Therapies
December 19, 2025
·
2 min read
Press Releases
DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy
December 18, 2025
·
9 min read
Press Releases
ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer
December 16, 2025
·
19 min read
